X-Ray Analysis & Clinical Assessment

What I See on This Chest X-Ray

1. Massively enlarged cardiac silhouette - the cardiothoracic ratio is clearly >0.5, consistent with severe cardiomegaly
2. Left lower zone opacity - the VUNO AI system has highlighted a region in the left lower zone with 73% confidence for consolidation/opacity
3. Bilateral haziness in lower zones - suggesting pulmonary congestion or pleural effusions
4. Blunting of costophrenic angles - suggestive of bilateral pleural effusions, more prominent on the left
5. Upper lobe venous diversion - subtle increased vascular markings in upper zones

DIAGNOSIS

Primary: Congestive Heart Failure (CHF) with Cardiomegaly

• Likely Dilated Cardiomyopathy or Ischemic Cardiomyopathy
• With bilateral pleural effusions (L > R)
• The left lower zone 73% opacity may represent left lower lobe collapse/consolidation from the effusion compressing the lung, or associated pneumonia

IMMEDIATE INVESTIGATIONS TO ORDER

MEDICATIONS TO PRESCRIBE (Chronic HFrEF - Stage C)

1. DIURETIC (First priority - symptom relief)

• Tab. Furosemide 40 mg once daily in the morning
• (Titrate up to 80 mg if response is inadequate; monitor creatinine and potassium)

2. ACE INHIBITOR (Reduces mortality)

• Tab. Enalapril 2.5 mg BD (start low, titrate to 10 mg BD)
• OR Tab. Ramipril 2.5 mg OD (titrate to 10 mg OD)
• Hold if creatinine >2.5 or K+ >5.0 mEq/L

3. BETA BLOCKER (Reduces mortality - start only after patient is euvolemic/stable)

• Tab. Carvedilol 3.125 mg BD (start very low, titrate every 2 weeks)
• OR Tab. Bisoprolol 1.25 mg OD
• Do NOT start during acute decompensation

4. ALDOSTERONE ANTAGONIST

• Tab. Spironolactone 25 mg OD
• Reduces morbidity and mortality in moderate-severe HF
• Monitor potassium closely with ACEi

5. SGLT2 INHIBITOR (Modern HF therapy)

• Tab. Dapagliflozin 10 mg OD or Empagliflozin 10 mg OD
• Proven mortality benefit in HFrEF regardless of diabetes status

6. POTASSIUM SUPPLEMENTATION

• Tab. Potassium chloride (Syrup/tablet) as needed - especially with furosemide

LIFESTYLE ADVICE

• Salt restriction: < 2 g sodium per day
• Fluid restriction: 1.5 liters per day
• Daily weight monitoring - report if weight increases > 2 kg in 2 days
• No smoking, no alcohol
• Gentle walking as tolerated; avoid strenuous exertion until stabilized
• Elevate head of bed (if orthopnoea present)

REFERRAL

• Cardiology referral urgently for echocardiography and complete workup
• If the echo confirms severely reduced EF (<35%), consider referral for ICD implantation or cardiac resynchronization therapy (CRT) later

Important clinical note: The left lower zone opacity with 73% VUNO AI confidence requires follow-up. If the patient has fever, productive cough, or elevated WBC, treat for community-acquired pneumonia concurrently (e.g., Amoxicillin-clavulanate + Azithromycin). Repeat CXR after 4-6 weeks of diuresis to confirm resolution.

⚠️ Disclaimer: This is an educational analysis based on X-ray findings and the clinical history provided. Final treatment decisions must be made by the treating physician after complete clinical examination, full investigations, and informed patient consent. Drug doses need to be adjusted based on patient's weight, renal function, and BP.